CN104161048A - Use of pestalotiopsis uvicola metabolites in preventing and treating phytophthora capsici - Google Patents
Use of pestalotiopsis uvicola metabolites in preventing and treating phytophthora capsici Download PDFInfo
- Publication number
- CN104161048A CN104161048A CN201410335830.XA CN201410335830A CN104161048A CN 104161048 A CN104161048 A CN 104161048A CN 201410335830 A CN201410335830 A CN 201410335830A CN 104161048 A CN104161048 A CN 104161048A
- Authority
- CN
- China
- Prior art keywords
- fermentation
- culture
- gmh31
- uvicola
- pestalotiopsis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000002207 metabolite Substances 0.000 title claims abstract description 31
- 241000722919 Pestalotiopsis uvicola Species 0.000 title claims abstract description 13
- 241000233616 Phytophthora capsici Species 0.000 title claims abstract description 11
- 238000000855 fermentation Methods 0.000 claims abstract description 41
- 230000004151 fermentation Effects 0.000 claims abstract description 41
- 238000004321 preservation Methods 0.000 claims abstract description 7
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 claims description 24
- 241000894006 Bacteria Species 0.000 claims description 21
- 230000001580 bacterial effect Effects 0.000 claims description 20
- 239000000284 extract Substances 0.000 claims description 20
- 238000000034 method Methods 0.000 claims description 14
- 230000001954 sterilising effect Effects 0.000 claims description 14
- 239000012530 fluid Substances 0.000 claims description 12
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 9
- 239000008103 glucose Substances 0.000 claims description 9
- 239000007788 liquid Substances 0.000 claims description 9
- 239000007787 solid Substances 0.000 claims description 6
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims description 5
- 229930195725 Mannitol Natural products 0.000 claims description 5
- 239000001888 Peptone Substances 0.000 claims description 5
- 108010080698 Peptones Proteins 0.000 claims description 5
- 240000008042 Zea mays Species 0.000 claims description 5
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims description 5
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims description 5
- 230000004913 activation Effects 0.000 claims description 5
- 229940041514 candida albicans extract Drugs 0.000 claims description 5
- 235000005822 corn Nutrition 0.000 claims description 5
- 238000000605 extraction Methods 0.000 claims description 5
- 235000013312 flour Nutrition 0.000 claims description 5
- 239000000594 mannitol Substances 0.000 claims description 5
- 235000010355 mannitol Nutrition 0.000 claims description 5
- 235000019319 peptone Nutrition 0.000 claims description 5
- 238000004080 punching Methods 0.000 claims description 5
- 239000012138 yeast extract Substances 0.000 claims description 5
- 244000061456 Solanum tuberosum Species 0.000 claims description 4
- 235000002595 Solanum tuberosum Nutrition 0.000 claims description 4
- 238000003810 ethyl acetate extraction Methods 0.000 claims description 3
- 241000233866 Fungi Species 0.000 abstract description 20
- 241000271889 Artemisia japonica Species 0.000 abstract description 19
- 241000196324 Embryophyta Species 0.000 abstract description 19
- 235000017521 Artemisia japonica Nutrition 0.000 abstract description 15
- 230000002401 inhibitory effect Effects 0.000 abstract description 10
- 238000000926 separation method Methods 0.000 abstract description 10
- 208000031888 Mycoses Diseases 0.000 abstract description 7
- 230000000813 microbial effect Effects 0.000 abstract description 7
- 244000298697 Actinidia deliciosa Species 0.000 abstract description 6
- 235000009436 Actinidia deliciosa Nutrition 0.000 abstract description 6
- 238000005516 engineering process Methods 0.000 abstract description 3
- 244000005700 microbiome Species 0.000 abstract description 3
- 241000221696 Sclerotinia sclerotiorum Species 0.000 abstract description 2
- 244000053095 fungal pathogen Species 0.000 abstract 1
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 30
- 239000000243 solution Substances 0.000 description 17
- 241000699666 Mus <mouse, genus> Species 0.000 description 14
- 210000004027 cell Anatomy 0.000 description 12
- 239000001965 potato dextrose agar Substances 0.000 description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 11
- 230000000694 effects Effects 0.000 description 10
- 210000001519 tissue Anatomy 0.000 description 9
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 8
- 238000002360 preparation method Methods 0.000 description 8
- 239000000047 product Substances 0.000 description 8
- 239000003814 drug Substances 0.000 description 7
- 238000004659 sterilization and disinfection Methods 0.000 description 7
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 6
- 201000010099 disease Diseases 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 206010028980 Neoplasm Diseases 0.000 description 5
- 230000000259 anti-tumor effect Effects 0.000 description 5
- 230000001717 pathogenic effect Effects 0.000 description 5
- 238000011160 research Methods 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 210000004881 tumor cell Anatomy 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 230000037396 body weight Effects 0.000 description 4
- 239000001963 growth medium Substances 0.000 description 4
- 230000005764 inhibitory process Effects 0.000 description 4
- 239000002609 medium Substances 0.000 description 4
- 239000000575 pesticide Substances 0.000 description 4
- 238000002137 ultrasound extraction Methods 0.000 description 4
- 206010008342 Cervix carcinoma Diseases 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 241001529936 Murinae Species 0.000 description 3
- 206010039491 Sarcoma Diseases 0.000 description 3
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 239000006285 cell suspension Substances 0.000 description 3
- 201000010881 cervical cancer Diseases 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 238000003304 gavage Methods 0.000 description 3
- 206010073071 hepatocellular carcinoma Diseases 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 244000052769 pathogen Species 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- 238000012216 screening Methods 0.000 description 3
- 239000008223 sterile water Substances 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 235000009051 Ambrosia paniculata var. peruviana Nutrition 0.000 description 2
- 235000003097 Artemisia absinthium Nutrition 0.000 description 2
- 235000017731 Artemisia dracunculus ssp. dracunculus Nutrition 0.000 description 2
- 235000003261 Artemisia vulgaris Nutrition 0.000 description 2
- 240000006891 Artemisia vulgaris Species 0.000 description 2
- 241000246500 Gentianella aspera Species 0.000 description 2
- 238000012449 Kunming mouse Methods 0.000 description 2
- 229930182555 Penicillin Natural products 0.000 description 2
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- 241000607479 Yersinia pestis Species 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 239000001138 artemisia absinthium Substances 0.000 description 2
- RCTYPNKXASFOBE-UHFFFAOYSA-M chloromercury Chemical compound [Hg]Cl RCTYPNKXASFOBE-UHFFFAOYSA-M 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 238000012136 culture method Methods 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 238000011010 flushing procedure Methods 0.000 description 2
- 238000007654 immersion Methods 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 239000012452 mother liquor Substances 0.000 description 2
- 231100000957 no side effect Toxicity 0.000 description 2
- 229940049954 penicillin Drugs 0.000 description 2
- 238000007789 sealing Methods 0.000 description 2
- QTENRWWVYAAPBI-YCRXJPFRSA-N streptomycin sulfate Chemical compound OS(O)(=O)=O.OS(O)(=O)=O.OS(O)(=O)=O.CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](N=C(N)N)[C@H](O)[C@@H](N=C(N)N)[C@H](O)[C@H]1O.CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](N=C(N)N)[C@H](O)[C@@H](N=C(N)N)[C@H](O)[C@H]1O QTENRWWVYAAPBI-YCRXJPFRSA-N 0.000 description 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 2
- 239000002352 surface water Substances 0.000 description 2
- 230000004083 survival effect Effects 0.000 description 2
- RTKIYNMVFMVABJ-UHFFFAOYSA-L thimerosal Chemical compound [Na+].CC[Hg]SC1=CC=CC=C1C([O-])=O RTKIYNMVFMVABJ-UHFFFAOYSA-L 0.000 description 2
- 229940033663 thimerosal Drugs 0.000 description 2
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 235000002566 Capsicum Nutrition 0.000 description 1
- 240000008574 Capsicum frutescens Species 0.000 description 1
- 235000004237 Crocus Nutrition 0.000 description 1
- 241000596148 Crocus Species 0.000 description 1
- 241000427940 Fusarium solani Species 0.000 description 1
- 235000011201 Ginkgo Nutrition 0.000 description 1
- 235000008100 Ginkgo biloba Nutrition 0.000 description 1
- 241000592346 Ginkgophyta Species 0.000 description 1
- 206010019345 Heat stroke Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 1
- 108091028043 Nucleic acid sequence Proteins 0.000 description 1
- 240000007817 Olea europaea Species 0.000 description 1
- 241000893212 Pestalotia Species 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 238000012300 Sequence Analysis Methods 0.000 description 1
- 208000004078 Snake Bites Diseases 0.000 description 1
- 240000003768 Solanum lycopersicum Species 0.000 description 1
- 241001512566 Valsa mali Species 0.000 description 1
- 210000000683 abdominal cavity Anatomy 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 239000011149 active material Substances 0.000 description 1
- 230000007059 acute toxicity Effects 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- 230000003044 adaptive effect Effects 0.000 description 1
- 238000012271 agricultural production Methods 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000000118 anti-neoplastic effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 230000009876 antimalignant effect Effects 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 244000030166 artemisia Species 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000000853 biopesticidal effect Effects 0.000 description 1
- 238000009534 blood test Methods 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000001390 capsicum minimum Substances 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 239000012531 culture fluid Substances 0.000 description 1
- 230000001472 cytotoxic effect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 239000000645 desinfectant Substances 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 241000957301 fungal endophyte Species 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 239000000976 ink Substances 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 239000002917 insecticide Substances 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 230000001665 lethal effect Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 231100001252 long-term toxicity Toxicity 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 238000005374 membrane filtration Methods 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 230000010355 oscillation Effects 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 230000008635 plant growth Effects 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 208000008128 pulmonary tuberculosis Diseases 0.000 description 1
- 238000009666 routine test Methods 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 210000005070 sphincter Anatomy 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 230000031068 symbiosis, encompassing mutualism through parasitism Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 231100000820 toxicity test Toxicity 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 231100000611 venom Toxicity 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 239000008215 water for injection Substances 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to the technical field of microorganisms, the artemisia japonica endophytic fungi is isolated from artemisia japonica plant living body which is collected from suburb of Guiyang City Guizhou Province by endophytic fungi separation technology, by microbial taxonomic identification, the artemisia japonica endophytic fungi is named as pestalotiopsis uvicola GMH31, the strain is preserved in China Center For Type Culture Collection (CCTCC), the preservation date is June 30, 2014, and the preservation registration number is CCTCC NO:M2014303. The most striking feature of the Pestalotiopsis uvicola GMH31 is that the fermentation liquor of the strain can produce active metabolites with inhibiting effects on kiwi fruit sclerotinia sclerotiorum, phytophthora capsici and other pathogenic fungi of plant fungal diseases, and the Pestalotiopsis uvicola is an important biological resource in agriculture.
Description
Technical field
The present invention relates to microbial technology field, especially relating to the outstanding Wei of plan Pestalotia endogenetic fungus that a strain derives from medicinal plant Artemisia japonica can the application of plan dish stey (Pestalotiopsis uvicola) GMH31 metabolite in agricultural.
Background technology
Plant endogenesis epiphyte (fungal endophyte) refers to the certain phase of the history of life or whole stage lives and health plant is respectively organized qualified intraorganic fungi.They and host plant, by the mutual symbiotic relation closely that formed, can promote the growth of plant, provide plant to tackle the adaptive capacity of coercing, and some plant endogenesis epiphytes also have medical value.From plant endogenesis epiphyte, find and find that reactive compound has become the another focus of domestic and international research.As Chinese patent literature CN201310194836.5 discloses endogenetic fungus (Metarrhizium) LD421 that in a strain rough gentian, separation obtains, can be used for preventing and treating rough gentian leaf blight; Patent application CN201210067829.4 discloses the endogenetic fungus fusarium solani T-7 that separation obtains from the tissues such as Root of Ginkgoes, stem, leaf, and Phytophthora capsici germ, tomato wilt bacterium, Valsa mali etc. are had to good inhibitory action.
Artemisia japonica (Artemisia japonica) is composite family sagebruss, its bitter, micro-sweet, cool in nature.Among the peoplely claim again soil purple (" Luchuan draft ") recklessly, stomachache spirit, bear's paw careless, with all herbal medicine.There is heat-clearing, cool blood, removing toxic substances, stomach invigorating hemostasia effect, be mainly used in treating cold, fever, heatstroke, malaria, pulmonary tuberculosis hectic fever, high blood pressure, infirmities and diseases, sphincter disturbance and venomous snake bite etc.Simultaneously also Artemisia japonica on the books is medicine food dual purpose plant, contains various active material, has immunity, antiviral, antitumor, hypoglycemic, the reducing blood lipid different physiological roles that protects the liver and delay senility etc.In addition, Artemisia japonica also can be used for preparing biopesticide, uses as insecticide.
The Main Means of controlling at present crop diseases and pest crop smothering in agricultural production process is chemical pesticide control, it is to alleviating disease pest and weed, ensure that the good harvest of crops high yield plays a positive role, but due to the mutual restriction interdependence between nature biotechnology, now do not advise too relying on chemical pesticide in the processing of carrying out disease.Therefore, to the research of plant endogenesis epiphyte, utilizing the relation of plant endogenesis epiphyte and the symbiosis of host plant biologically active, screen the endogenetic fungus with high bioactivity, further obtain activated product, is a large focus of studying this year.But, for a certain host plant, which kind of endogenetic fungus or which class endogenetic fungus have resisting pathogenic microbes activity actually, and in each endogenetic fungus, which kind of bacterium activity is the highest, whether separation and purification is easy, whether fermentation process is complicated etc., all need to carry out large quantity research and be confirmed, not yet finds the concrete report of Artemisia japonica endogenetic fungus and separation cultivation thereof and resisting pathogenic microbes activity, medical active application at present.
Summary of the invention
The object of the invention is, for the deficiency that chemicals is dangerous and microbial source drug variety is less, provides a kind of endogenetic fungus separating from medicinal plant Artemisia japonica---and You Wei can plan dish stey (Pestalotiopsis uvicola).
Endogenetic fungus of the present invention, to separate and obtain the medicinal plant Artemisia japonica (Artemisia japonica) from suburb, Guiyang City, Guizhou Province, called after Nei Shengyouwei can plan dish stey (Pestalotiopsis uvicola) GMH31, and the fermentating metabolism product of this bacterial strain has been carried out to multiple bioactivity research.This invention for microbial pesticide and medicine further development and exploitation good starting strain is provided.
Technical solution of the present invention is as follows:
The outstanding Wei of the present invention can plan dish stey separation, screening and identify:
Be in the Artemisia japonica blade gathering in suburb, Guiyang City, Guizhou Province in August, 2011, obtain and preserve through steps such as separation, purifying, cultivation, fermentation and determinations of activity; Being accredited as You Wei through microbial taxonomy can plan dish stey (Pestalotiopsis uvicola), name into You Wei can plan dish stey (Pestalotiopsis uvicola) GMH31.This bacterial strain is in the center preservation of Chinese Typical Representative culture collection, preservation date on June 30th, 2014, preservation registration number CCTCC NO:M2014303, Luojiashan, Wuchang, Wuhan City, Hubei Province, address.
Concrete isolated culture method is:
(1) preparation of Japanese wormwood herb botanical tissue: gather the leaf texture of Artemisia japonica, with running water flushing, the raw microorganism of table of removing sample surfaces, is then put in wind on clean gauze and dries;
(2) show sterilization and aseptic detection: the tissue block after drying is cut into suitable size, rinse well with sterile purified water, blade sterilization adopts 75% alcohol immersion 1-2min, 0.1%HgCl
2solution soaks 3-4min, then rinses to thimerosal noresidue with sterile purified water, blots after tissue segments remained on surface water droplet with sterilizing filter paper, is cut into the segment of organizing of diameter 4~6mm size;
(3) separation and purification of endogenetic fungus: will organize segment to be inoculated in to contain streptomycin sulphate (100 μ gmL after step (2) sterilization
-1) and penicillin (50 μ gmL
-1) PDA culture medium flat plate on, after sealing in 25-30 DEG C of constant temperature culture 2~7 days, from tissue block, grow to mycelium, adopt most advanced and sophisticated mycelia picking method, mycelia is transferred on purifying PDA culture medium flat plate, at 25-30 DEG C, carry out purifying and cultivate 5~9 days, grow complete bacterium colony, be Artemisia japonica endogenetic fungus.
Preferably, in described step (3), cultivation temperature is 28 DEG C, dull and stereotyped cultivation, and purifying incubation time is 7 days.
The outstanding Wei of this Artemisia japonica endogenetic fungus called after can plan dish stey GMH31, its solid culture is characterized as: it is 9cm that bacterium colony 28 DEG C of cultivations on PDA flat board extend to diameter for 8-9 days, bacteria colony white flocculence, colyliform expansion is not obvious, the light crocus in the back side, without wheel line, fruit body prepared Chinese ink shape, particle is larger, distributes more sparse.Micro-morphology: aceravlus black, closely spherical, just bury under raw Cuticle, the ripe rear epidermis of breaking through exposes, and is a point-like; Conidium 5 cells, two teloblasts colourless (being taper shape or triangle), intermediate cell be olive colour to brown (9.7~12.6 μ m), nearly spindle, upright, wall thickness, size is 19.7~23.5 × 5.5~6.6 μ m; Appendage and is born in conidial top, is 2~3, and angle is opened a business, and more elongated, length is 5.9~6.5 μ m, and bottom is colourless, triangle, the short or nothing of tailfiber.See Fig. 1, Fig. 2.
The molecular biological characteristics of bacterial strain GMH31: adopt molecular biology round pcr, determined dna sequence analysis, the ITSrDNA genome of bacterial strain GMH31 is made up of 495 bases (bp).Taking ITSrDNA sequence as fundamental construction phylogenetic tree, this bacterium is that You Wei can plan dish stey, sees Fig. 3.
Another object of the present invention is to provide the method for utilizing this bacterial strain fermentation liquor metabolite control fungal diseases of plants.
Above-mentioned purpose is achieved through the following technical solutions:
A preparation method who prevents and treats the microbial metabolic products of the fungal diseases of plants such as kiwi fruit brown rot and capsicum epidemic disease, carries out according to the following steps:
(1) activation culture of bacterial classification: can move on potato glucose PDA solid plate by plan dish stey GMH31 bacterial classification separating the outstanding Wei of preserving, under 28 ± 1 DEG C of conditions, cultivate, covering whole culture dish to mycelia, is that the punching of 7mm card punch obtains bacterium cake with diameter, for inoculating;
(2) liquid fermentation and culture: fermentation culture is to contain corn flour 10g, mannitol 20g, glucose 20g, yeast extract 5g, peptone 10g, KH in every 1000mL
2pO
40.5g, CaCO
315g, MgSO
47H
2o0.3g, the bottled fermentation culture 100mL of every 500mL triangle; Prepare rear 121 DEG C of sterilizing 20min, to be cooled to 40 DEG C under aseptic condition picking 1 diameter be 7mm bacterium cake, under 28 ± 1 DEG C of conditions, standing for fermentation cultivate 28-35 days;
(3) broth extraction: collect zymotic fluid after fermentation, add the ethyl acetate extraction of 1-3 times of volume, take off a layer solution, again with the extracting n-butyl alcohol of 1-2 times of volume, after layering, get upper strata liquid, under vacuum condition, be concentrated into medicinal extract, obtain n-butanol zymotic fluid extract.
A further object of the present invention is to provide this strain fermentation mycelium metabolite in the antitumor application waiting in medicine of preparation.
Above-mentioned purpose is achieved through the following technical solutions:
A preparation method with the mycelium metabolite of antitumor activity, carries out according to the following steps:
(1) activation culture of bacterial classification: can move on potato glucose PDA solid plate by plan dish stey GMH31 bacterial classification separating the outstanding Wei of preserving, under 28 ± 1 DEG C of conditions, cultivate, covering whole culture dish to mycelia, is that the punching of 7mm card punch obtains bacterium cake with diameter, for inoculating;
(2) liquid fermentation and culture: fermentation culture is to contain corn flour 10g, mannitol 20g, glucose 20g, yeast extract 5g, peptone 10g, KH in every 1000mL
2pO
40.5g, CaCO
315g, MgSO
47H
2o0.3g, the bottled fermentation culture 100mL of every 500mL triangle; Prepare rear 121 DEG C of sterilizing 20min, to be cooled to 40 DEG C under aseptic condition picking 1 diameter be 7mm bacterium cake, under 28 ± 1 DEG C of conditions, standing for fermentation cultivate 28-35 days;
(3) mycelium extracts: after fermentation, collect mycelium, adding concentration is 30-90% aqueous acetone solution, make the concentration of mycelium in aqueous acetone solution be less than or equal to 0.50g/L, be ultrasonic extraction 2-5 time under 40KHz, the condition of 30min/ time at power, then under equal conditions add again equal-volume ethyl acetate ultrasonic extraction 2-5 time, filter, collect upper strata ethyl acetate solution, under vacuum condition, be concentrated into medicinal extract, obtain ethyl acetate mycelium extract.
Beneficial effect of the present invention:
The one, the present invention from medicinal plant Artemisia japonica blade, separate metabolite Activities of Some Plants fungal disease pathogen and tumour cell are had to strong inhibiting outstanding Wei can plan dish stey GMH31, this in agricultural, prevent and treat fungal diseases of plants pathogen and pharmaceutically the developing of anti-malignant tumor source new drugs a kind of microbial strains is provided.
The 2nd, the invention provides utilize outstanding Wei can plan dish stey GMH31 fermentation obtain the method for active-fermented broth metabolite; This metabolite can be applicable to the control of fungal diseases of plants, for the exploitation of disinfectant use in agriculture has increased new approach.
The 3rd, the invention provides utilize outstanding Wei can plan dish stey GMH31 fermentation obtain the method for active mycelium body metabolite; This metabolite can be applicable to the preparation of antineoplastic, for the exploitation in the new source of medical has increased new approach.
Brief description of the drawings
Fig. 1 is the lithograph that You Wei can plan dish stey (Pestalotiopsis uvicola) GMH31 bacterial strain.
Fig. 2 is the conidium figure that You Wei can plan dish stey (Pestalotiopsis uvicola) GMH31 bacterial strain.
Fig. 3 is the gene tree graph that You Wei can plan dish stey (Pestalotiopsis uvicola) GMH31 bacterial strain.
Embodiment
In order to make those of ordinary skill in the art better understand the present invention, the applicant has carried out series of experiment research, to prove effect of the present invention.
Below, enumerate embodiment the present invention is further described, but the present invention is not limited to following embodiment.
The outstanding Wei of embodiment 1:(can plan dish stey GMH31 isolation and screening)
The present invention gathers medicinal plant---the healthy leaves of Artemisia japonica in suburb, Guiyang City, Guizhou Province in August, 2011, through steps such as surface sterilization, endogenetic fungus separation, cultivation, fermentation, determination of activity and the screenings to inhibition fungal diseases of plants pathogen active bacterial strain and tumor cell line, therefrom obtaining outstanding Wei can plan dish stey GMH31, preserves.
Concrete isolated culture method is: the preparation of (1) Japanese wormwood herb botanical tissue: gather the leaf texture of Artemisia japonica, with running water flushing, the raw microorganism of table of removing sample surfaces, is then put in wind on clean gauze and dries;
(2) show sterilization and aseptic detection: the tissue block after drying is cut into suitable size, rinse well with sterile purified water, blade sterilization adopts 75% alcohol immersion 1min, 0.1%HgCl
2solution soaks 3min, then rinses to thimerosal noresidue with sterile purified water, blots after tissue segments remained on surface water droplet with sterilizing filter paper, is cut into the segment of organizing of diameter 4~6mm size;
(3) separation and purification of endogenetic fungus: will organize segment to be inoculated in to contain streptomycin sulphate (100 μ gmL after step (2) sterilization
-1) and penicillin (50 μ gmL
-1) PDA culture medium flat plate on, after sealing, in 28 DEG C of constant temperature culture 5 days, from tissue block, grow to mycelium, adopt most advanced and sophisticated mycelia picking method, mycelia is transferred on purifying PDA culture medium flat plate, at 28 DEG C, carry out purifying and cultivate 7 days, grow complete bacterium colony, be Artemisia japonica endogenetic fungus.
Outstanding Wei can plan dish stey GMH31 Antibacterial Activity:
Learn from else's experience the zymotic fluid 1mL of 0.22 μ m membrane filtration in sterile petri dish, the PDA medium that is cooled to 50 DEG C with 9mL mixes rapidly, after cooling, put respectively the kiwi fruit brown rot germ that 1 diameter is 7mm (Sclerotinia sclerotiorum) or phytophthora blight of pepper (Phytophthora capsici) etc. for examination bacterium bacterium cake in each medium plane, bacterium cake is connected to culture dish central authorities (culture dish diameter is 9cm), put 28 DEG C of cultivation 72h in incubator, process in contrast with sterile water, repeat 3 times; Adopt right-angled intersection method to measure colony diameter, calculate inhibiting rate: I (%)=[(contrast colony diameter-processing colony diameter)/(contrast colony diameter-7)] × 100% with following formula.
Measurement result shows: You Wei can be respectively 82.8% and 86.9% to the inhibiting rate of kiwi fruit brown rot germ and phytophthora blight of pepper by plan dish stey GMH31 metabolite.
Outstanding Wei can plan dish stey GMH31 inhibition tumor cell strain growth measurement:
By tumour cell suspension inoculation, in 96 well culture plates, every hole 100 μ L, after standard conditions cultivation 12h, add respectively the culture fluid (concentration is respectively 20 μ g/mL and 200 μ g/mL) that contains contrast or fermentation mycelium extract.Standard conditions cultivate respectively 12,24,48,72,96h, finish front 4h in cultivation, and each hole adds 0.5% MTT solution 20 μ L.After cultivation finishes, abandon supernatant, every hole adds dimethyl sulfoxide (DMSO) (DMSO) 150 μ L cessation reactions, in automatic microplate reader, measure the optical density value (OD value) of each hole at wavelength 492nm place, calculate cell inhibitory rate: I (%)=[1-medicine feeding hole OD value/control wells OD value] × 100%.Inhibiting rate >50%'s is the bacterial strain with tumor cytotoxic activity.
Measurement result shows: concentration is that the outstanding Wei of 20 μ g/mL can plan dish stey GMH31 metabolite, in the time of 72h, to Murine Ascitic Hepatoma Cells H
22, mouse hydroperitoneum type cervical cancer cell U
14with mouse hydroperitoneum type sarcoma cell S
180inhibiting rate be respectively 86.1%, 92.4% and 77.9%.
The outstanding Wei of embodiment 2:(can plan dish stey GMH31 fermentating metabolism product preparation method)
Carry out according to the following steps:
(1) activation culture of bacterial classification: can move on potato dextrose agar PDA solid plate by plan dish stey GMH31 bacterial classification separating the outstanding Wei of preserving, under 28 ± 1 DEG C of conditions, cultivate, covering whole culture dish to mycelia, is that the punching of 7mm card punch obtains bacterium cake with diameter, for inoculating;
(2) liquid fermentation and culture: fermentation culture is to contain corn flour 10g, mannitol 20g, glucose 20g, yeast extract 5g, peptone 10g, KH in every 1000mL
2pO
40.5g, CaCO
315g, MgSO
47H
2o0.3g, the bottled fermentation culture 100mL of every 300mL triangle; Prepare rear 121 DEG C of sterilizing 20min, to be cooled to 40 DEG C of bacterium cakes that picking 1 diameter is 7mm under aseptic condition, under 28 ± 1 DEG C of conditions, standing for fermentation is cultivated 30 days;
(3) broth extraction: collect zymotic fluid after fermentation, add the extraction of equal-volume ethyl acetate, take off a layer solution, then use equal-volume extracting n-butyl alcohol, get upper strata liquid after layering, be concentrated into medicinal extract under vacuum condition, obtain n-butanol zymotic fluid extract;
(4) mycelium extracts: after fermentation, collect mycelium, adding concentration is 80% aqueous acetone solution, make the concentration of mycelium in aqueous acetone solution be less than or equal to 0.50g/L, be ultrasonic extraction 4 times under 40KHz, the condition of 30min/ time at power, then under equal conditions add again equal-volume ethyl acetate ultrasonic extraction 4 times, filter, collect upper strata ethyl acetate solution, under vacuum condition, be concentrated into medicinal extract, obtain ethyl acetate mycelium extract.
Outstanding Wei described in following examples 3 can plan dish stey GMH31 metabolite be n-butanol zymotic fluid extract prepared in 2 times methods of embodiment (3); The percentage composition of described product is mass/volume percentage.
The outstanding Wei of embodiment 3:(can the inhibitory action of plan dish stey GMH31 zymotic fluid metabolite to kiwi fruit brown rot germ and phytophthora blight of pepper)
(1) accurately taking You Wei can plan dish stey GMH31 n-butanol zymotic fluid extract 0.1g, adds the sterile water of 10mL volume, and ultrasonic oscillation fully dissolves, and is finally configured to the mother liquor that concentration is 10g/L;
(2) Antibacterial Activity: get above-mentioned mother liquor and be diluted to respectively the solution that concentration is 1000mg/L and 500mg/L, get each concentration solution 1mL in sterile petri dish, be cooled to the PDA medium of 50 DEG C with 9mL and mix rapidly (You Wei can plan dish stey GMH31 metabolite final concentration be 100mg/L and 50mg/L), after cooling, put respectively in each medium plane kiwi fruit brown rot germ and the phytophthora blight of pepper bacterium cake that 1 diameter is 7mm, bacterium cake is connected to culture dish central authorities (culture dish diameter is 9cm), put 28 DEG C of cultivation 36h in incubator, process in contrast with conventional chemical medicament and sterile water, repeat 3 times, adopt right-angled intersection method to measure colony diameter, calculate inhibiting rate: I (%)=[(contrast colony diameter-processing colony diameter)/(contrast colony diameter-7)] × 100% with following formula.
(3) product of the present invention and conventional pesticide control efficiency comparative trial: result of the test is in table 1.As seen from Table 1, You Wei is can plan dish stey GMH31 metabolite inhibition slightly excellent compared with conventional chemical medicament, and safety.
The outstanding Wei of table 1 can the inhibition of plan dish stey GMH31 metabolite to confession examination disease fungus
"-" represents not test (N.T.).
Outstanding Wei described in following examples 4 can plan dish stey GMH31 metabolite be ethyl acetate mycelium extract prepared in 2 times methods of embodiment (4); The percentage composition of described product is mass/volume percentage.
The outstanding Wei of embodiment 4:(can the inhibitory action of plan dish stey GMH31 fermentation mycelium metabolite to Murine Ascitic Hepatoma Cells H22, mouse hydroperitoneum type cervical cancer cell U14 and mouse hydroperitoneum type sarcoma cell S180)
(1) accurately taking You Wei can plan dish stey GMH31 ethyl acetate mycelium extract, after first dissolving with a small amount of ethanol, then is mixed with the solution that concentration is 0.2mg/mL with water for injection dilution, fills with and feeds administration for mouse;
(2) preparation of tumor cell line animal model: respectively Murine Ascitic Hepatoma Cells H22, mouse hydroperitoneum type cervical cancer cell U14 and mouse hydroperitoneum type sarcoma cell S180 are made to 1 × 10
6cell suspension, gets this cell suspension and only injects mouse (t is sheerly some of 615 mouse, Balb/c mouse, kunming mouse, body weight 20-22g) abdominal cavity with 0.5ml/.Be divided at random control group, experimental group next day.Every mouse stomach 1mL physiological saline of control group, the ethyl acetate mycelium extract aqueous solution 1mL that the above-mentioned concentration of every mouse stomach of experimental group is 0.2mg/mL.Gavage 5 days continuously, observes mouse storaging current, calculates survival rate and increase in life span.
(3) the anti-tumor in vivo effect test of product of the present invention: result of the test is in table 2.As seen from Table 2, You Wei can plan dish stey GMH31 metabolite to suppress tumor effect better, and safety.
The outstanding Wei of table 2 can plan dish stey GMH31 metabolite anti-tumor in vivo result of the test
Survival rate: observe 60 days bearing tumors not above.
The outstanding Wei of embodiment 5:(can plan dish stey GMH31 fermentation mycelium metabolite animal toxicity test)
(1) acute toxicity experience: get 40 of kunming mices (male and female half and half), body weight 22-22g, gavage 3 times in 24 hours, the dose that makes accumulative total is above-mentioned medicinal 225 times, Continuous Observation mouse 14 days, without the phenomena of mortality and bad reaction, illustrate that this fermentation mycelium metabolite has no side effect.
(2) long term toxicity test: get 40 of the rats (male and female half and half) that body weight is suitable, be divided at random two groups, one group was that You Wei can plan dish stey GMH31 fermentation mycelium metabolite experimental group, with 100 times of continuous gavages of above-mentioned routine test dosage 60 days; Another is organized as adding equivalent distilled water control group, found that, biped is all without death and bad reaction during this period, and two treated animal appetite, stool and urine and body weight be there was no significant difference (p>0.05) statistically; There was no significant difference (p>0.05) between two groups of routine blood test indexs such as blood leucocyte, red blood cell and clamour version; Two treated animal internal organs anatomy and pathologies observations, all without abnormal pathological phenomenon, illustrate that this fermentation mycelium metabolite long-term taking is safe and reliable.
(3) whole experimental result shows: You Wei can have direct lethal effect to tumour by plan dish stey GMH31 fermentation mycelium metabolite, and has obvious treatment function of tumor; And have no side effect, safe and reliable.
Claims (3)
1. outstanding Wei can the application of plan dish stey (Pestalotiopsis uvicola) GMH31 metabolite in control phytophthora blight of pepper (Phytophthora capsici), described outstanding Wei can plan dish stey GMH31 in the center preservation of Chinese Typical Representative culture collection, preservation registration number is CCTCC NO:M2014303.
2. application as claimed in claim 1, is characterized in that: described metabolite is prepared by the following method:
(1) activation culture of bacterial classification: can move on potato glucose PDA solid plate by plan dish stey GMH31 bacterial classification separating the outstanding Wei of preserving, under 28 ± 1 DEG C of conditions, cultivate, covering whole culture dish to mycelia, is that the punching of 7mm card punch obtains bacterium cake with diameter, for inoculating;
(2) liquid fermentation and culture: fermentation culture is to contain corn flour 10g, mannitol 20g, glucose 20g, yeast extract 5g, peptone 10g, KH in every 1000mL
2pO
40.5g, CaCO
315g, MgSO
47H
2o0.3g, the bottled fermentation culture 100mL of every 500mL triangle; Prepare rear 121 DEG C of sterilizing 20min, to be cooled to 40 DEG C under aseptic condition picking 1 diameter be 7mm bacterium cake, under 28 ± 1 DEG C of conditions, standing for fermentation cultivate 28-35 days;
(3) broth extraction: collect zymotic fluid after fermentation, add the ethyl acetate extraction of 1-3 times of volume, take off a layer solution, again with the extracting n-butyl alcohol of 1-2 times of volume, after layering, get upper strata liquid, under vacuum condition, be concentrated into medicinal extract, obtain n-butanol zymotic fluid extract.
3. application as claimed in claim 1, is characterized in that: described metabolite is prepared by the following method:
(1) activation culture of bacterial classification: can move on potato glucose PDA solid plate by plan dish stey GMH31 bacterial classification separating the outstanding Wei of preserving, under 28 ± 1 DEG C of conditions, cultivate, covering whole culture dish to mycelia, is that the punching of 7mm card punch obtains bacterium cake with diameter, for inoculating;
(2) liquid fermentation and culture: fermentation culture is to contain corn flour 10g, mannitol 20g, glucose 20g, yeast extract 5g, peptone 10g, KH in every 1000mL
2pO
40.5g, CaCO
315g, MgSO
47H
2o0.3g, the bottled fermentation culture 100mL of every 500mL triangle; Prepare rear 121 DEG C of sterilizing 20min, to be cooled to 40 DEG C under aseptic condition picking 1 diameter be 7mm bacterium cake, under 28 DEG C of conditions, standing for fermentation cultivate 30 days;
(3) broth extraction: collect zymotic fluid after fermentation, add isopyknic ethyl acetate extraction, take off a layer solution, use again isopyknic extracting n-butyl alcohol, after layering, get upper strata liquid, under vacuum condition, be concentrated into medicinal extract, obtain n-butanol zymotic fluid extract.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410335830.XA CN104161048B (en) | 2014-07-15 | 2014-07-15 | Outstanding Wei can be intended coiling the application of stey metabolite in control phytophthora blight of pepper |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410335830.XA CN104161048B (en) | 2014-07-15 | 2014-07-15 | Outstanding Wei can be intended coiling the application of stey metabolite in control phytophthora blight of pepper |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104161048A true CN104161048A (en) | 2014-11-26 |
CN104161048B CN104161048B (en) | 2016-02-17 |
Family
ID=51904977
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410335830.XA Expired - Fee Related CN104161048B (en) | 2014-07-15 | 2014-07-15 | Outstanding Wei can be intended coiling the application of stey metabolite in control phytophthora blight of pepper |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104161048B (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108624527A (en) * | 2018-05-12 | 2018-10-09 | 湖南科技学院 | A kind of ginkgo source growth-promoting preparation of prevention ginger bacterial wilt |
-
2014
- 2014-07-15 CN CN201410335830.XA patent/CN104161048B/en not_active Expired - Fee Related
Non-Patent Citations (5)
Title |
---|
J.Y.LI ET AL.,: "Ambuic acid,a highly functionalized cyclohexenone with antifungal activity from Pestalotiopsis spp. and Monochaetia sp.", 《PHYTOCHEMISTRY》, vol. 56, 31 December 2001 (2001-12-31), pages 463 - 468, XP004291791, DOI: doi:10.1016/S0031-9422(00)00408-8 * |
何劲等: "植物内生菌及其在农业和医学上的用途", 《贵州农业科学》, vol. 34, no. 3, 31 December 2006 (2006-12-31), pages 113 - 115 * |
易晓华等: "除虫菊内生拟盘多毛孢Y1菌株的生物学特性及其对植物病原菌的抑制作用", 《浙江大学学报(农业与生命科学版)》, vol. 34, no. 5, 31 December 2008 (2008-12-31), pages 516 - 524 * |
白志强等: "内生拟盘多毛孢菌化学成分研究进展", 《天然产物研究与开发》, vol. 25, 31 December 2013 (2013-12-31) * |
钱一鑫等: "青蒿内生真菌的抗肿瘤抗氧化活性", 《菌物研究》, vol. 12, no. 1, 31 March 2014 (2014-03-31), pages 44 - 50 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108624527A (en) * | 2018-05-12 | 2018-10-09 | 湖南科技学院 | A kind of ginkgo source growth-promoting preparation of prevention ginger bacterial wilt |
Also Published As
Publication number | Publication date |
---|---|
CN104161048B (en) | 2016-02-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102363750B (en) | Insecticidal fungus and application thereof | |
CN102204570A (en) | Application of alternaria alternate metabolic products in cucumber rhizoctonia solani prevention and control | |
CN101965848B (en) | Biogenic pesticide for efficiently preventing and controlling main diseases of Camellia oleifera and application thereof | |
CN102552335A (en) | Traditional Chinese medicine health care product, its preparation method and its application | |
CN106942301A (en) | A kind of botanical pesticide preparation of prevention and control rice blast and preparation method thereof | |
CN103255068B (en) | Paraconiothyrium sp. | |
CN103103127B (en) | Culture method for microalgae | |
CN104161048B (en) | Outstanding Wei can be intended coiling the application of stey metabolite in control phytophthora blight of pepper | |
CN104212723B (en) | One strain Herba Artemisiae Japonicae Nei Shengyouwei can intend dish stey and application thereof | |
CN106701624B (en) | The Te Jila bacillus of one plant of antagonism fructus lycii root rot and its application | |
CN104161049B (en) | Outstanding Wei can be intended coiling the application of stey metabolite in control kiwi fruit brown rot germ | |
CN103087949B (en) | Biocontrol endophytic actinomycetes- streptomyces sioyaensis | |
CN108471749A (en) | Aminoglycan ester and its application | |
CN103222479B (en) | Use of Streptomyces sioyaensis metabolite in prevention and control of Colletotrichum lindemuthianum | |
CN102210329B (en) | Application of Aspergillus restrictus 28-generation product on preventing and curing cucumber Rhizoctonia solani | |
CN104161777A (en) | Application of pestalotiopsis uvicola metabolites in preparation of antitumor drugs | |
CN103222483B (en) | Use of Streptomyces sioyaensis metabolite in prevention and control of Botrytis cinerea | |
CN103947684A (en) | Application of mixed formula preparation in prevention and treatment of brown planthopper | |
CN108991021A (en) | A kind of preparation method passing the compound formulation fallen ill for preventing and treating soil | |
CN103222480B (en) | Use of Streptomyces sioyaensis metabolite in prevention and control of Rhizoctonia solani | |
CN103222481B (en) | Use of Streptomyces sioyaensis metabolite in prevention and control of Thanatephorus cucumeris | |
CN103070198B (en) | Preparation method of fungal disease prevention metabolite | |
AU2020103248A4 (en) | The preparation and application of antifungal extracts from Oxytropis falcate Bunge | |
CN103222482B (en) | Use of Streptomyces sioyaensis metabolite in prevention and control of Alternaria solani | |
CN107475128A (en) | A kind of production method of selenium-rich cordyceps |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20160217 |